TAKEDA PHARMACEUTICALS COMPANY LTD has a total of 19 patent applications. It decreased the IP activity by 25.0%. Its first patent ever was published in 2006. It filed its patents most often in China, Colombia and South Africa. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are UNIV CHANG GUNG SCIENCE & TECHNOLOGY, SHANDONG LUOXIN PHARMACEUTICAL GROUP STOCK CO LTD and BETTA PHARMACEUTICALS CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 7 | |
#2 | Colombia | 5 | |
#3 | South Africa | 2 | |
#4 | Argentina | 1 | |
#5 | Canada | 1 | |
#6 | Chile | 1 | |
#7 | Peru | 1 | |
#8 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Chemical engineering |
# | Name | Total Patents |
---|---|---|
#1 | Hoashi Yasutaka | 3 |
#2 | Nangia Avinash | 2 |
#3 | Daini Masaki | 2 |
#4 | Asano Yasutomi | 2 |
#5 | Ogino Masaki | 2 |
#6 | Lodin Unchalee | 2 |
#7 | Okochi Kazuhiro | 2 |
#8 | Kojima Takuto | 2 |
#9 | Okawa Tomohiro | 2 |
#10 | Hirano Sayuri | 1 |
Publication | Filing date | Title |
---|---|---|
CN108026088A | As hdac inhibitor oxadiazole derivatives |